Navepegritide (YUVIWEL®) is a prodrug of C-type natriuretic peptide (CNP) developed by Ascendis Pharma for the treatment...
...CNP exhibits a uniform distribution and spherical morphology with an average diameter of 40 nm. CNP, mainly in combinati...
...CNP) affects about half of individuals post-spinal cord injury (SCI) and is often resistant to treatment. The risk for C...
...CNP system is involved in MI and that A-13p modulates CNP expression, highlighting CNP as a potential target for therape...
...CNPs), formulated by using natural cell membranes as drug substances, have emerged as a promising alternative. Acting as...
...CNP) NPs, exerts protective effects through activation of particulate guanylyl cyclase receptors and, downstream, cyclic...
...CNPs@TiO2) to decouple polarization efficiency from conductive percolation. The graphene-like sp2-rich carbon nanopartic...
...CNP via NPR-B, mediating natriuretic, vasodilatory, and antifibrotic effects. The cGMP-independent axis includes NPR C-m...
...CNPs reduced OD600 from 1.6846 to 0.53275 (68.38%), whereas the reduction with uncoated CNPs was from 1.5267 to 1.196 (2...
BackgroundChronic neck pain (CNP) is a major cause of disability. Cervical sagittal alignment, neck awareness, and proba...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
